Trial Profile
A prospective cohort study evaluating effect of recombinant HB vaccine containing AS04 adjuvant (HBV-AS04) in hepatitis B virus-seronegative patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2016
Price :
$35
*
At a glance
- Drugs Hepatitis B vaccine recombinant (Primary) ; AS04B
- Indications Hepatitis B
- Focus Adverse reactions; Therapeutic Use
- 05 Nov 2016 New trial record